India to Brazil: Amiodarone Export Trade Route
India has recorded 103 verified shipments of Amiodarone exported to Brazil, representing a combined trade value of $6.3M USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $60.9K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 65% of total export value with 60 shipments worth $4.1M USD. On the buying side, M/S. RANBAXY FARMACEUTICA LTDA : is the largest importer in Brazil with $3.1M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , ZYDUS LIFESCIENCES LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Amiodarone corridor is one of India's established pharmaceutical export routes, with 103 shipments documented worth a combined $6.3M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 65% of all export value, reflecting the consolidated nature of India's amiodarone manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $60.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with amiodarone's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 7.9%, placing it at rank #18 among India's top amiodarone export destinations globally.
On the import side, key buyers of Indian amiodarone in Brazil include M/S. RANBAXY FARMACEUTICA LTDA :, M/S. RANBAXY FARMACEUTICA LTDA : , RANBAXY FARMACEUTICA LIMITEDA and 10 others. M/S. RANBAXY FARMACEUTICA LTDA : is the single largest importer with 38 shipments valued at $3.1M USD.
